Literature DB >> 11873017

First, do no harm: a call for emphasizing adherence and HIV prevention interventions in active antiretroviral therapy programs in the developing world.

Danielle Popp, Jeffrey D Fisher.   

Abstract

Entities:  

Mesh：

Year:  2002        PMID： 11873017     DOI： 10.1097/00002030-200203080-00025

Source DB:  PubMed          Journal:  AIDS        ISSN： 0269-9370            Impact factor:   4.177


× No keyword cloud information.
  9 in total

Review 1.  Primary drug resistance in South Africa: data from 10 years of surveys.

Authors:  Justen Manasa; David Katzenstein; Sharon Cassol; Marie-Louise Newell; Tulio de Oliveira
Journal:  AIDS Res Hum Retroviruses       Date:  2012-03-12       Impact factor: 2.205

Review 2.  Antiretroviral adherence in a resource-poor setting.

Authors:  Catherine Orrell
Journal:  Curr HIV/AIDS Rep       Date:  2005-11       Impact factor: 5.071

Review 3.  Adherence-resistance relationships to combination HIV antiretroviral therapy.

Authors:  David R Bangsberg; Deanna L Kroetz; Steven G Deeks
Journal:  Curr HIV/AIDS Rep       Date:  2007-05       Impact factor: 5.071

4.  Should patents for antiretrovirals be waived in the developing world? Annual Varsity Medical Debate--London, 21 January 2011.

Authors:  Fenella Corrick; Robert Watson; Sanjay Budhdeo
Journal:  Philos Ethics Humanit Med       Date:  2011-07-08       Impact factor: 2.464

5.  Prevalence of transmitted HIV drug resistance in Iran between 2010 and 2011.

Authors:  Fatemeh Jahanbakhsh; Junko Hattori; Masakazu Matsuda; Shiro Ibe; Seyed-Hamid R Monavari; Arash Memarnejadian; Mohammad R Aghasadeghi; Ehsan Mostafavi; Minoo Mohraz; Hossain Jabbari; Kianoush Kamali; Hossein Keyvani; Kayhan Azadmanesh; Wataru Sugiura
Journal:  PLoS One       Date:  2013-04-23       Impact factor: 3.240

6.  Explaining adherence success in sub-Saharan Africa: an ethnographic study.

Authors:  Norma C Ware; John Idoko; Sylvia Kaaya; Irene Andia Biraro; Monique A Wyatt; Oche Agbaji; Guerino Chalamilla; David R Bangsberg
Journal:  PLoS Med       Date:  2009-01-27       Impact factor: 11.069

7.  Virological efficacy and emergence of drug resistance in adults on antiretroviral treatment in rural Tanzania.

Authors:  Asgeir Johannessen; Ezra Naman; Sokoine L Kivuyo; Mabula J Kasubi; Mona Holberg-Petersen; Mecky I Matee; Svein G Gundersen; Johan N Bruun
Journal:  BMC Infect Dis       Date:  2009-07-07       Impact factor: 3.090

8.  Is the "3 by 5" initiative the best approach to tackling the HIV pandemic?

Authors:  Jim Yong Kim; Arthur Ammann
Journal:  PLoS Med       Date:  2004-11-30       Impact factor: 11.069

9.  HIV-1 transmitted drug resistance mutations among antiretroviral therapy-Naïve individuals in Surabaya, Indonesia.

Authors:  Tomohiro Kotaki; Siti Qamariyah Khairunisa; Adiana Mutamsari Witaningrum; Muhammad Qushai Yunifiar M; Septhia Dwi Sukartiningrum; Muhammad Noor Diansyah; Retno Pudji Rahayu; ᅟ Nasronudin; Masanori Kameoka
Journal:  AIDS Res Ther       Date:  2015-02-22       Impact factor: 2.250
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.